<DOC>
	<DOCNO>NCT01508390</DOCNO>
	<brief_summary>In study , participant standard ADT undergo standard XRT prostate at-risk lymph node IMRT . The subsequent *boost* RT prostate alone give use CyberKnife , rather use standard IMRT . This study also see CyberKnife affect quality participant 's life .</brief_summary>
	<brief_title>Hypofractionated Stereotactic Body Radiation Therapy Boost Prostate</brief_title>
	<detailed_description>In study , participant standard androgen deprivation therapy undergo standard radiation therapy prostate at-risk lymph node intensity-modulated radiation therapy ( IMRT ) . The subsequent *boost* radiation therapy prostate alone give use CyberKnife , rather use standard IMRT . This study also see CyberKnife affect quality participant 's life .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Histologically proven adenocarcinoma prostate a. Gleason score ( 210 ) b. Biopsy within six month date registration 2 . Clinical stage ( American Joint Committee Cancer [ AJCC ] 7th Edition ) a. Tstage determine physical exam i. MRI finding ( e.g . extracapsular extension ) influence Tstaging , note later analysis b. Nstage determine use abdominopelvic CT scan c. Mstage determine physical exam , CT and/or MRI , bone scan 3 . Patients must belong one follow risk group : . Very High risk : cT3 Gleason 810 PSA less 150 b . High risk : cT1T2 Gleason 810 PSA less 150 c. Moderate high risk : cT3 Gleason 7 PSA d. Intermediate high risk ( ) cT3 Gleason 6 PSA least 30 e. Intermediate high risk ( b ) : cT1T2 Gleason 7 PSA least 30 4 . Patient plan undergo standard androgen deprivation therapy initial Intensity Modulated Radiation Therapy ( IMRT ) prostate atrisk lymph node . 5 . Prostate volume great 20 cc less 100 cc 6 . Eastern Cooperative Oncology Group ( ECOG ) performance status 01 7 . Patient agree complete questionnaire 8 . Signed Institutional Review Board ( IRB ) approve informed consent 1 . No prior prostate surgery prostate cancer treatment 2 . No prior radiotherapy pelvis 3 . No implanted hardware material would prohibit appropriate treatment plan treatment delivery 4 . No chemotherapy malignancy last 5 year . 5 . No history invasive malignancy ( basal squamous skin cancer ) last 5 year . 6 . No history horseshoe kidney 7 . No diagnosis inflammatory bowel disease 8 . No heart pacemaker , No metallic foreign body ( metal sliver ) eye , No aneurysm clip brain 9 . Must able tolerate confinement MRI procedure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>prostate</keyword>
</DOC>